Status:
COMPLETED
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Hepatitis B
Hepatocellular Carcinoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
By detecting polymorphisms of IL-1β and TNF-α,this study aims to find the effects of cytokine gene polymorphisms(and their interaction) on susceptibility and severity of HBV-related HCC.
Detailed Description
Hepatitis B virus (HBV)infection is the major risk factor for chronic liver disease and hepatocellular carcinoma (HCC). Host immunogenetic factors contribute to HBV-associated liver damage and/or carc...
Eligibility Criteria
Inclusion
- HBsAg-positive patients
Exclusion
- HBsAg-negative patients
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00629486
Start Date
January 1 2007
End Date
May 1 2008
Last Update
April 18 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Chung-Ho Hospital
Kaohsiung City, Kaohsiung, Taiwan, 807
2
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Kaohsiung, Taiwan, 807